• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

G 蛋白偶联受体 CB1 和 CB2 的结构与功能研究进展。

Structural and functional insights into the G protein-coupled receptors: CB1 and CB2.

机构信息

Department of Molecular Medicine, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology, Jupiter, FL 33458, U.S.A.

The Skaggs Graduate School of Chemical and Biological Sciences at Scripps Research, La Jolla, CA 92037, U.S.A.

出版信息

Biochem Soc Trans. 2023 Aug 31;51(4):1533-1543. doi: 10.1042/BST20221316.

DOI:10.1042/BST20221316
PMID:37646476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10586759/
Abstract

The cannabinoid receptors CB1 and CB2 mediate a variety of physiological processes and continue to be explored as desirable drug targets. Both receptors are activated by the endogenous endocannabinoids and the psychoactive components of marijuana. Over the years, many efforts have been made to make selective ligands; however, the high degree of homology between cannabinoid receptor subtypes introduces challenges in studying either receptor in isolation. Recent advancements in structure biology have resulted in a surge of high-resolution structures, enriching our knowledge and understanding of receptor structure and function. In this review, of recent cannabinoid receptor structures, key features of the inactive and active state CB1 and CB2 are presented. These structures will provide additional insight into the modulation and signaling mechanism of cannabinoid receptors CB1 and CB2 and aid in the development of future therapeutics.

摘要

大麻素受体 CB1 和 CB2 介导多种生理过程,并且继续作为理想的药物靶点进行探索。这两种受体都被内源性大麻素和大麻的精神活性成分激活。多年来,人们做出了许多努力来制造选择性配体;然而,大麻素受体亚型之间的高度同源性给单独研究任何一种受体都带来了挑战。结构生物学的最新进展产生了大量高分辨率结构,丰富了我们对受体结构和功能的认识。在这篇综述中,介绍了最近的大麻素受体结构,包括 CB1 和 CB2 的无活性和活性状态的关键特征。这些结构将为大麻素受体 CB1 和 CB2 的调节和信号转导机制提供更多的见解,并有助于开发未来的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c9/10586759/621a15419761/BST-51-1533-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c9/10586759/4c615a937b83/BST-51-1533-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c9/10586759/621a15419761/BST-51-1533-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c9/10586759/4c615a937b83/BST-51-1533-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78c9/10586759/621a15419761/BST-51-1533-g0002.jpg

相似文献

1
Structural and functional insights into the G protein-coupled receptors: CB1 and CB2.G 蛋白偶联受体 CB1 和 CB2 的结构与功能研究进展。
Biochem Soc Trans. 2023 Aug 31;51(4):1533-1543. doi: 10.1042/BST20221316.
2
Crystal Structure of the Human Cannabinoid Receptor CB2.人源大麻素受体 CB2 的晶体结构
Cell. 2019 Jan 24;176(3):459-467.e13. doi: 10.1016/j.cell.2018.12.011. Epub 2019 Jan 10.
3
The pharmacology of cannabinoid receptors and their ligands: an overview.大麻素受体及其配体的药理学:概述
Int J Obes (Lond). 2006 Apr;30 Suppl 1:S13-8. doi: 10.1038/sj.ijo.0803272.
4
Pharmacological actions of cannabinoids.大麻素的药理作用。
Handb Exp Pharmacol. 2005(168):1-51. doi: 10.1007/3-540-26573-2_1.
5
Molecular basis for ligand modulation of the cannabinoid CB receptor.大麻素 CB 受体配体调节的分子基础。
Br J Pharmacol. 2022 Jul;179(14):3487-3495. doi: 10.1111/bph.15627. Epub 2021 Aug 12.
6
Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.内源性大麻素、植物大麻素和合成大麻类似物的非 CB1、非 CB2 受体:重点是 G 蛋白偶联受体和瞬时受体电位通道。
J Neuroimmune Pharmacol. 2010 Mar;5(1):103-21. doi: 10.1007/s11481-009-9177-z. Epub 2009 Oct 22.
7
Structural and Functional Insights into Cannabinoid Receptors.大麻素受体的结构与功能研究进展
Trends Pharmacol Sci. 2020 Sep;41(9):665-677. doi: 10.1016/j.tips.2020.06.010. Epub 2020 Jul 29.
8
Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB, CB and CB/CB heteromer receptors.大麻素 CB、CB 和 CB/CB 杂二聚体受体作用的大麻二酚和大麻萜酚型植物大麻素的药理学数据。
Pharmacol Res. 2020 Sep;159:104940. doi: 10.1016/j.phrs.2020.104940. Epub 2020 May 26.
9
Novel cannabinoid receptors.新型大麻素受体。
Br J Pharmacol. 2007 Nov;152(5):567-75. doi: 10.1038/sj.bjp.0707481. Epub 2007 Oct 1.
10
Endocannabinoids and cannabinoid receptor genetics.内源性大麻素与大麻素受体遗传学
Prog Neurobiol. 2002 Apr;66(5):307-44. doi: 10.1016/s0301-0082(02)00007-2.

引用本文的文献

1
Utilization of Cannabidiol in Post-Organ-Transplant Care.大麻二酚在器官移植后护理中的应用。
Int J Mol Sci. 2025 Jan 15;26(2):699. doi: 10.3390/ijms26020699.
2
Exploring G Protein-Coupled Receptors in Hematological Cancers.探索血液系统癌症中的G蛋白偶联受体
ACS Pharmacol Transl Sci. 2024 Nov 21;7(12):4000-4009. doi: 10.1021/acsptsci.4c00473. eCollection 2024 Dec 13.
3
Current and Potential Use of Biologically Active Compounds Derived from L. in the Treatment of Selected Diseases.来源于L.的生物活性化合物在特定疾病治疗中的当前及潜在应用。

本文引用的文献

1
Structural basis for activation of CB1 by an endocannabinoid analog.内源性大麻素类似物激活 CB1 的结构基础。
Nat Commun. 2023 May 9;14(1):2672. doi: 10.1038/s41467-023-37864-4.
2
Structural basis of selective cannabinoid CB receptor activation.选择性大麻素 CB 受体激活的结构基础。
Nat Commun. 2023 Mar 15;14(1):1447. doi: 10.1038/s41467-023-37112-9.
3
Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1.大麻素受体 CB1 的变构调节的分子机制。
Int J Mol Sci. 2024 Nov 27;25(23):12738. doi: 10.3390/ijms252312738.
4
Cannabis and cancer: unveiling the potential of a green ally in breast, colorectal, and prostate cancer.大麻与癌症:揭示绿色盟友在乳腺癌、结直肠癌和前列腺癌中的潜力
J Cannabis Res. 2024 May 16;6(1):24. doi: 10.1186/s42238-024-00233-z.
Nat Chem Biol. 2022 Aug;18(8):831-840. doi: 10.1038/s41589-022-01038-y. Epub 2022 May 30.
4
A Genetically Encoded F-19 NMR Probe Reveals the Allosteric Modulation Mechanism of Cannabinoid Receptor 1.一种基因编码的 F-19 NMR 探针揭示了大麻素受体 1 的别构调节机制。
J Am Chem Soc. 2021 Oct 13;143(40):16320-16325. doi: 10.1021/jacs.1c06847. Epub 2021 Oct 1.
5
Prediction of the Binding Affinities and Selectivity for CB1 and CB2 Ligands Using Homology Modeling, Molecular Docking, Molecular Dynamics Simulations, and MM-PBSA Binding Free Energy Calculations.使用同源建模、分子对接、分子动力学模拟和 MM-PBSA 结合自由能计算预测 CB1 和 CB2 配体的结合亲和力和选择性。
ACS Chem Neurosci. 2020 Apr 15;11(8):1139-1158. doi: 10.1021/acschemneuro.9b00696. Epub 2020 Apr 2.
6
Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-G Complex Structures.大麻素受体-G 复合物结构揭示的激活和信号转导机制。
Cell. 2020 Feb 20;180(4):655-665.e18. doi: 10.1016/j.cell.2020.01.008. Epub 2020 Jan 30.
7
Cryo-EM Structure of the Human Cannabinoid Receptor CB2-G Signaling Complex.冷冻电镜结构解析人类大麻素受体 CB2-G 信号复合物
Cell. 2020 Feb 20;180(4):645-654.e13. doi: 10.1016/j.cell.2020.01.007. Epub 2020 Jan 30.
8
Structure of an allosteric modulator bound to the CB1 cannabinoid receptor.别构调节剂与 CB1 大麻素受体结合的结构。
Nat Chem Biol. 2019 Dec;15(12):1199-1205. doi: 10.1038/s41589-019-0387-2. Epub 2019 Oct 28.
9
Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure.大麻素受体相互作用蛋白 1a(CRIP1a):功能与结构。
Molecules. 2019 Oct 12;24(20):3672. doi: 10.3390/molecules24203672.
10
Molecular switches in GPCRs.G 蛋白偶联受体中的分子开关。
Curr Opin Struct Biol. 2019 Apr;55:114-120. doi: 10.1016/j.sbi.2019.03.017. Epub 2019 May 10.